Aralast

Understanding Aralast® NP

Aralast® NP is a medication used to treat alpha-1 antitrypsin deficiency (AATD), a genetic disorder that can lead to chronic obstructive pulmonary disease (COPD) and emphysema due to low levels of alpha-1 antitrypsin (AAT)—a protein that protects the lungs from damage.

How Aralast® NP Works:

  • Replaces missing AAT, helping protect the lungs from further damage
  • Slows the progression of lung disease in patients with AATD
  • Reduces lung inflammation, lowering the risk of COPD-related complications

FDA Approval:

  • Aralast® NP: Approved in 2002

For more information, please visit the Aralast® NP patient website and speak with your healthcare provider to determine if Aralast® NP is the right treatment option for you.

Referral Form

What it Treats

Manufacturer

Baxalta US Inc.

Class

Alpha1-Proteinase Inhibitor (Human)

Prescribed by

How Administered

IV Infusion

Frequency

Administered weekly.

Length of infusion

About 15 minutes

Other Treatments

Get in touch

Phone

732 931 4633
732 413 2421 (FAX)

Address

Monmouth County
Long Branch, NJ 07740